#Vaccines13

16 Jan 2026

Gagandeep Kang on Vaccines, Surveillance and Child Health in India

Gagandeep Kang, a leading expert on enteric diseases, urges India to prepare tools to prevent viral outbreaks. She helped develop indigenous rotavirus vaccines, built surveillance networks and now works at the Gates Foundation.

A1 A2 B1 B2 Read

Photo by AMIT RANJAN, Unsplash

31 Dec 2025

Adding antibodies could make flu vaccines cut spread

New research shows adding certain infection-made antibodies to flu vaccines may lower how much infected people spread the virus. The study followed households using tests and models and was published in Nature Communications.

Level

A1 A2 B1 B2 Read

30 Dec 2025

Experimental vaccine gives lasting protection in mice against CCHF

A new mouse study reports an experimental vaccine that produced rapid protection and antibodies that lasted up to 18 months. Researchers say a booster strengthened and extended immune responses and plan manufacturing steps before human trials.

Level

A1 A2 B1 B2 Read

28 Dec 2025

AI finds new target for monkeypox

Researchers used artificial intelligence to identify a viral protein called OPG153 that many antibodies bind. Laboratory tests and mouse studies confirmed the finding, which could help develop cheaper vaccines or antibody treatments.

Level

A1 A2 B1 B2 Read

22 Dec 2025

New vaccine shows protection against melioidosis

Researchers have developed a vaccine that protected nonhuman primates from melioidosis, a serious disease caused by soil bacteria. The team hopes to move the vaccine to human trials after encouraging lab and animal results.

Level

A1 A2 B1 B2 Read

8 Dec 2025

T cells in tonsils differ from T cells in blood

A study found that T cells in the tonsils are different from T cells in blood. Researchers say doctors and scientists should study tissue T cells as well as blood to understand vaccines and immunotherapies.

Level

A1 A2 B1 B2 Read

3 Dec 2025

Brazil approves single-dose dengue vaccine

Brazil’s Butantan-DV single-dose dengue vaccine was authorised on 26 November for people aged 12–59. Trials with 16,000 volunteers showed high efficacy, and the vaccine will join the national programme in early 2026.

Level

A1 A2 B1 B2 Read

2 Dec 2025

Emory study: 2023–24 COVID vaccine gives lasting antibodies

Emory University measured antibody responses in 24 people after the 2023–24 monovalent vaccine targeting Omicron XBB.1.5. The study found long-lasting antibodies, cross-reactive protection with the ancestral WA1 strain, and a 2.8-fold boost from immune imprinting.

Level

A1 A2 B1 B2 Read

1 Dec 2025

Study: Year‑round RSV Immunization Could Reduce Big Outbreaks

A study in Science Advances finds that offering RSV immunizations year‑round would lower the chance of large seasonal outbreaks in the United States. Researchers compared spread in cities and rural areas and tested seasonal versus year‑round schedules.

Level

A1 A2 B1 B2 Read

26 Nov 2025

Cholera spreads where water and health systems fail

Cholera spread widely in 2024, with 560,823 reported cases and 6,028 deaths. Conflict, climate shocks and damaged water and health services drove outbreaks, while vaccines and better water and sanitation are key to preventing deaths.

Level

A1 A2 B1 B2 Read

24 Oct 2025

Durban conference urges local vaccine production

CPHIA 2025 met in Durban to discuss how Africa can become more self-reliant in health. Leaders presented a US$3.2 billion plan to expand regional vaccine manufacturing and discussed funding pressures and local innovation.

Level

A1 A2 B1 B2 Read

1 Aug 2025

Africa plans to make more vaccines

The African Union aims for the continent to make most of its own vaccines by 2040. Africa now produces very few vaccines, and plans include new partnerships, factories and international funding, but experts warn of big challenges.

Level

A1 A2 B1 B2 Read

6 Feb 2025

Marburg outbreak in Kigali, Rwanda

In July 2024 Rwanda detected its first Marburg outbreak in Kigali, starting among health workers. Authorities and the WHO led a fast response with genomic tests and treatments; most confirmed cases recovered and the outbreak ended in November.

Level

A1 A2 B1 B2 Read